ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
More News related to ARIA
- ARIAD to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
- JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight
- ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
- ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) reports Q3 loss of $0.21, versus the analyst estimate of ($0.18). Revenue for the quarter was $2.16 billion, which compares to the estimate of $2.59 billion.
Related Categories
EarningsStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
